[HTML][HTML] Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study

K Hosokawa, K Abe, K Funakoshi, Y Tamura… - Journal of Thrombosis …, 2023 - Elsevier
Background Chronic thromboembolic pulmonary hypertension (CTEPH) requires lifelong
anticoagulation. Long-term outcomes of CTEPH under current anticoagulants are unclear …

Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study

K Hosokawa, K Abe, K Funakoshi… - … of thrombosis and …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Chronic thromboembolic pulmonary hypertension (CTEPH) requires lifelong
anticoagulation. Long-term outcomes of CTEPH under current anticoagulants are unclear …

Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study

K Hosokawa, K Abe, K Funakoshi, Y Tamura… - Journal of Thrombosis …, 2023 - jthjournal.org
Background Chronic thromboembolic pulmonary hypertension (CTEPH) requires lifelong
anticoagulation. Long-term outcomes of CTEPH under current anticoagulants are unclear …

Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study.

K Hosokawa, K Abe, K Funakoshi… - … of Thrombosis and …, 2023 - europepmc.org
Background Chronic thromboembolic pulmonary hypertension (CTEPH) requires lifelong
anticoagulation. Long-term outcome of CTEPH under current anticoagulants is unclear …

[引用][C] Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study

細川和也 - Journal of Thrombosis and Haemostasis, 2023 - cir.nii.ac.jp
Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral
anticoagulants and warfarin: a Japanese prospective cohort study | CiNii Research CiNii 国立 …

Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study

K Hosokawa, K Abe, K Funakoshi… - Journal of …, 2023 - kyushu-u.elsevierpure.com
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) requires lifelong
anticoagulation. Long-term outcomes of CTEPH under current anticoagulants are unclear …

[引用][C] Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study

K Hosokawa, K Abe, K Funakoshi, Y Tamura… - Journal of Thrombosis …, 2023 - cir.nii.ac.jp
Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral
anticoagulants and warfarin: a Japanese prospective cohort study | CiNii Research CiNii 国立 …

Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study

K Hosokawa, K Abe, K Funakoshi, Y Tamura… - Journal of Thrombosis …, 2023 - jthjournal.org
Background Chronic thromboembolic pulmonary hypertension (CTEPH) requires lifelong
anticoagulation. Long-term outcomes of CTEPH under current anticoagulants are unclear …